Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: mantle7 who wrote (1451)	7/14/1998 9:30:00 AM
From: Jeffrey L. Henken	Read Replies (1) \| Respond to of 2887

According to the American BioMed 10K stents can be delivered by a variety of methods. It's true that I like other LONG investors was disappointed to see AVE buy Bard's Coronary Catheter business but not like I would have been if they spent 4 times the money to buy Schneider. ABMI has a very diverse product line in development. Take the OmniCath alone and AVE, JNJ and many other companies would still have an excellent reason to buy or form a strategic partnership with ABMI. You call me dishonest? I remember when you tried to tell everyone AVE was already bundling their stents. You call me dishonest? What's your real name. You call me dishonest? What is your position in ABMI? Just how short are you? Finally you stated the following: >By the way there are at least 5 other AAA stent grafts either on the market or close to it (see Guidant's purchase of EVTI, Pfizer's purchase of Corvita to name two).< Give us some URL's to prove your statements. How close to the market are these products? Come on show ME some of your own due diligence, not just your ability to attack someone long on a stock!